Could a 70-year-old antipsychotic drug help fight deadly brain cancer?
NCT ID NCT05190315
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 24 times
Summary
This early-phase study tested whether adding chlorpromazine, a medication used for mental health conditions, to standard chemotherapy and radiation is safe for people with newly diagnosed glioblastoma, an aggressive brain cancer. Ten adult patients participated to find the best dose and check for side effects. The goal was to see if this combination could be studied further to improve disease control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA MULTIFORME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Iowa Hospitals & Clinics
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.